Desafíos en el manejo del sarcoma de Ewing en una paciente testigo de Jehová / Challenges in the care of Ewing's sarcoma in a Jehovah's Witness patient

El sarcoma de Ewing es una neoplasia de hueso y tejidos blandos, cuyo manejo se relaciona con toxicidad hematológica. Este aspecto representa un desafío médico y ético en los pacientes testigos de Jehová quienes, por sus creencias religiosas, rechazan la aplicación de hemoderivados, con riesgo de que se descontinúe la quimioterapia o de que se utilicen dosis subóptimas. Se presenta el caso de una mujer colombiana de 34 años, testigo de Jehová, con diagnóstico de sarcoma de Ewing con estadificación clínica IIB (T1N0M0) en las regiones maxilar y mandibular izquierdas, tratada con quimioterapia, quien presentó un valor mínimo de hemoglobina de hasta 4,5 g/dl y tuvo indicación quirúrgica como parte del tratamiento. En estos pacientes, la decisión de practicar una transfusión comprende implicaciones éticas que requieren alternativas terapéuticas y un abordaje multidisciplinario.

Ewing's sarcoma is a bone and soft tissue neoplasm, whose management is related to hematological toxicity. This aspect represents a medical and ethical challenge in Jehovah's Witnesses patients, who, due to their religious beliefs, reject the blood component transfusion, with the risk of discontinuing chemotherapy or using suboptimal doses. We present the case of a 34-year-old Colombian woman, Jehovah's Witness, diagnosed with Ewing's sarcoma with clinical stage IIB (T1N0M0) in the left maxillary and mandibular regions, treated with chemotherapy, who presented a hemoglobin nadir of up to 4.5 g/dL, and surgical indication as part of the treatment. In these patients, the transfusion decision has ethical implications that require therapeutic alternatives and a multidisciplinary approach.

Clinical diagnosis and treatment of hereditary thrombocytopenia and purpura: a report of five cases and literature review / 中华血液学杂志

Objective: To report the clinical manifestations and laboratory features of five patients with congenital thrombotic thrombocytopenic purpura (cTTP) and explore its standardized clinical diagnosis and treatment along with a review of literature. Methods: Clinical data of patients, such as age of onset, disease manifestation, personal history, family history, and misdiagnosed disease, were collected. Treatment outcomes, therapeutic effects of plasma infusion, and organ function evaluation were observed. The relationship among the clinical manifestations, treatment outcomes, and ADAMTS13 gene mutation of patients with cTTP was analyzed. Additionally, detection of ADAMTS13 activity and analysis of ADAMTS13 gene mutation were explored. Results: The age of onset of cTTP was either in childhood or adulthood except in one case, which was at the age of 1. The primary manifestations were obvious thrombocytopenia, anemia, and different degrees of nervous system involvement. Most of the patients were initially suspected of having immune thrombocytopenia. Acute cTTP was induced by pregnancy and infection in two and one case, respectively. ADAMTS13 gene mutation was detected in all cases, and there was an inherent relationship between the mutation site, clinical manifestations, and degree of organ injury. Therapeutic or prophylactic plasma transfusion was effective for treating cTTP. Conclusions: The clinical manifestations of cTTP vary among individuals, resulting in frequent misdiagnosis that delays treatment. ADAMTS13 activity detection in plasma and ADAMTS13 gene mutation analysis are important bases to diagnose cTTP. Prophylactic plasma transfusion is vital to prevent the onset of the disease.

Validation of blood components transport through a pneumatic tube system

ABSTRACT Introduction: Urgent blood component transfusions may be life-saving for patients in hemorrhagic shock. Measures to reduce the time taken to provide these transfusions, such as uncrossmatched transfusion or abbreviated testing, are available. However, transport time is still an additional delay and the use of a pneumatic tube system (PTS) may be an alternative to shorten the transport time of blood components. Objectives: To assess pneumatic tube system transportation of blood components based on a validation protocol. Methods: Pre- and post-transport quality control laboratory parameters, visual appearance, transport time and temperature of the packed red blood cells (RBCs), thawed fresh plasma (TFP), cryoprecipitate (CR), and platelet concentrate (PC) were evaluated. Parameters were compared between transport via pneumatic tube and courier. Results: A total of 23 units of RBCs, 50 units of TFP, 30 units of CR and ten units of PC were evaluated. No statistically significant differences were found between pre- and post-transport laboratory results. There was also no difference in laboratory parameters between transport modalities (PTS versus courier). All blood components transported matched regulatory requirements for quality criteria. The temperature during transport remained stable and the transport time via PTS was significantly shorter than the courier's transport time (p < 0.05). Conclusion: The PTS was considered a fast, safe and reliable means of transportation for blood components, also securing quality prerequisites.

Protocolo de transfusão maciça: experiência no atendimento ao trauma / Massive transfusion protocol: experience in trauma care

Introdução: O trauma é uma das principais causas de morte no mundo e a hemorragia é responsável por 30% a 40% da mortalidade relacionada ao trauma. O estabelecimento de um protocolo de transfusão maciça (PTM) oferece oportunidade de medidas preventivas de controle de danos ao doente com choque hemorrágico grave. Objetivo: analisar dados epidemiológicos dos pacientes submetidos ao PTM em instituição de referência em trauma. Métodos: estudo quantitativo, envolvendo pacientes submetidos ao PTM no período de janeiro a dezembro de 2018. Dados sanguíneos, identificação do paciente, local do trauma, tipo de acidente, informações clínicas e desfecho foram obtidos por meio de revisão de prontuários e informações coletadas no núcleo transfusional do hospital. A análise estatística foi feita com o programa Statistical Package for the Social Sciences (SPSS) versão 23. Resultados: 306 pacientes foram avaliados, houve predominância do sexo masculino e idade de 18 a 30 anos. 55,9% dos pacientes eram procedentes de Fortaleza. O grupo sanguíneo predominante foi O, a maioria fator Rh positivo. O tórax foi o local mais comum de trauma. A maioria dos casos foi relacionada a trauma penetrante, sendo 53,6% por armas de fogo e 8,5% por armas brancas. As medianas do Escore ABC, de concentrado de hemácias e de plasma fresco usados foram de 2. 29,7% tiveram óbito em 24 horas e apenas o local do trauma - abdome - revelou-se como fator protetor para esse desfecho. Conclusão: observou-se a inexistência de associações significativas entre as variáveis do protocolo e o desfecho clínico de óbito.

Introduction: Trauma is one of the main causes of death in the world and hemorrhage is responsible for 30% to 40% of trauma-related mortality. The establishment of a massive transfusion protocol (TMP) offers the opportunity for preventive measures to control damage to the patient with severe hemorrhagic shock. Objective: to analyze epidemiological data of patients submitted to the MTP in a trauma reference institution. Methods: this is a study retrospective with a quantitative approach, involving patients undergoing MTM from January to December 2018. Blood data, patient identification, trauma site, accident type, clinical information and outcome were obtained through review of medical records and information collected at the hospital transfusion center. Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) version 23. Results: 306 patients were evaluated, there was a predominance of males and ages from 18 to 30 years. 55.9% of the patients were from Fortaleza. The predominant blood group was O, being the majority with Rh positive factor. The thorax was the most common site of trauma. Most cases were related to penetrating trauma, being 53.6% for firearms and 8.5% for white weapons. Median ABC score, concentration of red blood cells and fresh plasma used were 2. 29.7% were dead in 24 hours and only the trauma site - abdomen - was revealed as a protective factor for this outcome. Conclusion: it was observed, after completing the study, the inexistence of significant associations between the protocol variables and the clinical death outcome.

Transfusão maciça em pacientes vítimas de trauma: uma coorte não concorrente / Massive transfusion in trauma patients: a non-concurrent cohort study

As causas externas estão entre os principais motivos de óbito no mundo e, dentre elas, o trauma se destaca por causar óbitos e incapacitações permanentes. A perda sanguínea maciça é a principal causa de morte evitável no trauma. Nos casos de hemorragias volumosas, a transfusão maciça de hemocomponentes pode ser necessária; entretanto aspectos sobre o procedimento são controversos na literatura. No Brasil, estudos sobre a transfusão maciça, ainda que escassos, ressaltam a elevada mortalidade e a necessidade de maior conhecimento de enfermeiros e equipes sobre a transfusão. Assim, este estudo objetivou analisar os aspectos epidemiológicos das transfusões maciças em pacientes vítimas de trauma, em um hospital referência neste tipo de atendimento em Belo Horizonte, Minas Gerais. Trata-se de um estudo de coorte não concorrente, em que foram analisados os registros de transfusão maciça de 110 pacientes vítimas de trauma, com idade superior a 18 anos, admitidos no período compreendido entre janeiro de 2019 e junho de 2020. Os dados foram obtidos por meio dos registros da agência transfusional do hospital e dos prontuários dos pacientes. Para a análise, foi empregada a estatística descritiva e inferencial, utilizando frequência simples e acumulada, medidas de tendência central e dispersão, análise de perdas de informações, bem como estatística Kappa, estimativa de incidência, estatística de Kaplan-Meier e teste log-rank. Em 78,18% dos casos houve a ocorrência de trauma contuso, provocado por colisões (40,00%) e atropelamentos (18,18%). O maior número de pacientes era do sexo masculino com mediana da idade de 36,5 anos. As Unidades de Suporte Avançado do Serviço de Atendimento Móvel de Urgência conduziram 45,37% das vítimas ao hospital. À admissão, a mediana dos dados dos pacientes indicava alteração do sensório (Escala de Coma de Glasgow 13), pressão arterial sistólica limítrofe (90 mmHg) e taquicardia (110 BPM). Ocorreram 45 óbitos, sendo 19,09% em até 6 horas após a admissão, 12,73% entre 6 e 24 horas e 9,09% após 24 horas da admissão. Infecção, sepse e insuficiência renal aguda foram complicações mais relatadas na internação, sendo os mais acometidos os pacientes vítimas de trauma contuso com traumatismo cranioencefálico. No momento da alta, os pacientes apresentavam alguma limitação, demanda de cuidado ou recomendação de acompanhamento ou nova cirurgia. Em 77,27% dos casos o protocolo de transfusão de emergências foi acionado, e a mediana do tempo entre a admissão e a primeira dispensação de hemocomponente foi de 19 minutos. Índice de choque (com ponto de corte de 0,9) e a escala Assessment of Blood Consumption (com ponto de corte de 2,0) tiveram uma concordância moderada (42,77%/ p<0,001), pelo Teste de Kappa, para predizer a necessidade de transfusão maciça. A incidência de óbitos foi de 40,90%, sendo a densidade para esse grupo de pacientes de 13,57 (10,13-18,17 IC95%) por mil pessoas-dia. A probabilidade de óbitos foi maior entre pacientes que não fizeram uso de plaquetas e ácido tranexâmico, não havendo diferença estatisticamente significativa em relação aos que não usaram tais substâncias. Identificou-se que a probabilidade de óbito dentre os pacientes que fizeram uso de volumes iguais ou superiores a 10 unidades de concentrado de hemácias foi superior àqueles pacientes que usaram volumes menores deste hemocomponente (p <0,05). A análise evidenciou que as vítimas de trauma submetidas à transfusão maciça são homens jovens, com quadro grave e com maior probabilidade de evoluir à óbito quando recebem volumes de concentrado de hemácias superiores a 3000ml. Os resultados fornecem informações que contribuem para a avaliação e acompanhamento destes pacientes, tais como sinais de gravidade e fatores a serem observados em sua evolução e que podem determinar maior probabilidade de óbito. Os dados reforçam, ainda, a importância do cuidado do ambiente pré-hospitalar após a alta.

External causes are among the main reasons off mortality in the world, with trauma accounting for a great number of deaths and permanent disability. Massive blood loss is the leading cause of preventable death in trauma. In cases of massive hemorrhages, massive transfusion of blood components may be necessary, however aspects about this procedure are controversial in the literature. Thus, this study aimed to analyze the epidemiological aspects of massive transfusions in trauma patients admitted in a hospital that is recognized for trauma care in Belo Horizonte, Minas Gerais. This is a non-concurrent cohort study, in which records of massive transfusions of 110 trauma patients aged over 18 years, admitted between january 2019 and june 2020, were analyzed. Data were obtained through the records of the hospital's transfusion agency and the patients' charts. For data analysis, descriptive and inferencial statistics were used, using simple and accumulated frequency, measures of central tendency and dispersion, analysis of information loss, as well as Kappa statistics, incidence estimation and Kaplan-Meier statistics and log-test. rank. In 78.18% of the cases there was the occurrence of blunt trauma, caused by most of the time by collisions (40.00%) and being run over (18.18%). The largest number of patients was male with a median age of 36.5 years. The Advanced Support Units of the Serviço de Atendimento Móvel de Urgência, was responsible for 45.37% of transport of the victims to the hospital. At admission, the median of patient data indicated sensory alteration (Glasgow Coma Scale 13), hypotension (90 mmHg) and tachycardia (110 BPM). There were 45 deaths, 19.09% within 6 hours of admission, 12.73% between 6 and 24 hours after admission, and 9.09% after 24 hours of admission. Infection, sepsis, and acute renal failure were the most reported complications during hospitalization, with patients suffering from blunt trauma with traumatic brain injury being the most affected. At the time of discharge, the patients had some limitation, demand for care or recommendation for follow-up or new surgery. In 77.27% of the cases, the emergency transfusion protocol was activated, and the median time between admission and the first dispensing of blood components was 19 minutes. Shock Index (with a cutoff point of 0.9) and the Assessment of Blood Consumption score (with a cutoff point of 2.0) had moderate agreement (42.77%/p<0.001), by the Kappa test, to predict the need for massive transfusion. The incidence density of deaths for this group of patients was 13.57 (10.13-18.17 95%CI) per thousand person-day. The probability of death was higher among patients who did not use platelets and tranexamic acid, with no statistically significant difference compared to those who did not use these substances. It was identified that the probability of death among patients who used volumes equal to or greater than 10 units of packed red blood cells was higher than for those patients who used smaller volumes of this blood component (p < 0.05). The analysis showed that trauma victims submitted to massive transfusiosns are young men, with severe condition and who are more likely to progress to deth when they receive volume of red blood cells greater than 3000ml. The results provide information that contributes to the assessment and follow-up of these patients, as signs of severity and factors to be observed in its evolution, as well as whic can determine a greater probability of death. They reinforce the importance of caring in pre-hospital environment, during hospital care and after discharge.

Therapeutic Effect of Convalescent Plasma Transfusion on Fulminant Viral Infectious Diseases--Review / 中国实验血液学杂志

Novel coronavirus disease 2019 (COVID-19) has started to erupt in Wuhan since December 2019, and then the cases of COVID-19 increased rapidly, the epidemic situation spreaded to most area of China. Owing to the lack of specific drugs at present, convalescent plasma therapy becomes an alternative treatment. However, the choice of the donor, suitable patients, timing of treatment, administrate dose, the advantages and disadvantages of the treatment are not clear. This article reviews the clinical studies and case reports of convalescent plasma therapy in several previous viral infectious diseases in order to provide clues for the treatment of COVID-19.

Clinical Blood Utilization of Patients at Different Ages for a Hospital in Sichuan from 2017 to 2018 / 中国实验血液学杂志

OBJECTIVE@#To analyze the use of blood products in patients at different ages.@*METHODS@#The clinical datas of the 10 784 patients transfused in Sichuan provincial people's hospital at 2017-2018 were retrospectively analyzed, and the basic condition of clinical blood using was statistically described. The patients were divided into the groups according to age and disease, then the use of various blood products in the patients with different diseases in different age groups was analyzed.@*RESULTS@#The age of blood transfusion patients was mainly 40-80 years old, and the most common disease was tumor(about 28%). The average annual transfusion volumes of red blood cells(RBC) were 24 936.5 U, of platelets(PLT) were 3 795 therapeutic doses of plasma were 2 455 500 ml, of cryoprecipitate were 3 461.5 U in our hospital. Most patients with hematologic malignancies and liver cirrhosis were transfused with two or more blood productions. For the patients with hematologic malignancies, the irradiated RBC (76.4%), PLT (67.8%), and suspended RBC (59.9%) were commonly used. And for liver cirrhosis patients, the suspended RBC (64.2%) and fresh frozen plasma(FFP) (59.4%) were commonly used. For the patients with trauma and chronic kidney disease(CKD), the suspended RBC (95.7% and 91.5%, respectively) was commonly used. In hematologic malignancies patients, the transfusion volume of irradiated RBC, PLT and FFP in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05); in trauma patients, the transfusion volume of suspended RBC in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05). In hematologic malignancies, trauma and liver cirrhosis patients, the proportion of PLT and/or plasma transfusion in the patients aged ≥60 years old was lower than that in patients aged<60 years old (P<0.05), and the elderly patients were more likely to receive RBC transfusion only.@*CONCLUSION@#There is a difference in the distribution of blood product between the patients aged<60 years old and ≥60 years old in the same disease, and it is more likely that the elderly patients (aged ≥60 years old) receive RBC transfusion only, and correction of hypoxia is a major clinical consideration, so blood using plans should be made according to the patient population, moreover, the different transfusion strategies should be developed for different population to maximize the efficiency of blood using.

Research Progress of in Vitro Experiment of Allergic Transfusion Reaction for Plasma Transfusion and Its Relative Mechanism---Review / 中国实验血液学杂志

Allergic transfusion reaction (ATR) caused by plasma transfusion is one of the main adverse transfusion reactions, and severe allergic reactions may even endanger the patient's life. Currently, ATR is mainly prevented and controlled by drug prevention and symptomatic treatment, and there still lack of preventive measures such as in vitro experiments. It has been shown that mast cells and basophils are the main effector cells of allergic reactions, and histamine is one of the main mediators of IgE-mediated allergic reactions. Some experiments can be used to identify patients with allergies or plasma components containing allergens, such as detection of serum-specific IgE, IgA, anti-IgA antibody, tryptase and histamine, mast cell degranulation test, basophil activation test, and so on. The basophil activation test can also be used for functional matching of plasma in vitro. Research of in vitro experiment of ATR is good for directing the precise infusion of plasma, reducing waste of resources, and avoiding the risk of blood transfusion. As a pre-transfusion laboratory test for clinical use, in vitro experiment of functional matching provides a new way to prevent ATR.

Influence of deep invasive tumor thrombus on the surgical treatment and prognosis of patients with non-metastatic renal cell carcinoma complicated with venous tumor thrombus / 北京大学学报(医学版)

OBJECTIVE@#To evaluate the impact of deep invasive tumor thrombus on the surgical complexity and prognosis of patients with renal cell carcinoma complicated with inferior vena cava tumor thrombus.@*METHODS@#We retrospectively reviewed the clinical data of 94 patients with non-metastatic renal cell carcinoma complicated with inferior vena cava tumor thrombus, who underwent surgical treatment in Peking University Third Hospital from January 2017 to June 2020. The patient's general condition, clinicopathological characteristics, surgery and survival information were collected. The patients were divided into two groups based on the intra-operative findings of tumor thrombus adhesion to the venous wall, of which 64 cases were in the deep invasive tumor thrombus (DITT) group and 30 cases were in the non-invasive tumor thrombus (NITT) group. Chi-square, t test and Mann-Whitney U test were used for categorical and continuous variables respectively. Kaplan-Meier plots and multivariable Cox regressions were performed to evaluate the influence of DITT on the prognosis of the patients with renal cell carcinoma with inferior vena cava tumor thrombus.@*RESULTS@#DITT significantly increase the difficulty of surgery for the patients with renal cell carcinoma with venous tumor thrombus, which was mainly reflected in the longer operation time (362.5 vs. 307.5 min, P=0.010), more surgical bleeding (1 200 vs. 450 mL, P=0.006), more surgical blood transfusion (800 vs. 0 mL, P=0.021), more plasma transfusion (200 vs. 0 mL, P=0.001), a higher proportion of open surgery (70.3% vs. 36.7%, P=0.002), a longer post-operative hospital stay (9.5 vs. 8 days, P=0.036), and a higher proportion of post-operative complications (46.9% vs. 13.8%, P=0.002). DITT was associated with worse overall survival of the patients with renal cell carcinoma with inferior vena cava tumor thrombus (P=0.022). Even in the multivariate analysis, DITT was still a poor prognostic factor for the overall survival of these patients [HR: 4.635 (1.017-21.116), P=0.047].@*CONCLUSION@#For patients with non-metastatic renal cell carcinoma with inferior vena cava tumor thrombus, DITT will significantly increase the difficulty of surgery, and may lead to poor prognosis.

Mortality in civilian trauma patients and massive blood transfusion treated with high vs low plasma: red blood cell ratio. Systematic review and meta-analysis / Mortalidad en pacientes con trauma civil y transfusion masiva tratados con una relación alta de plasma: globulos rojos versus una relacion baja. Revision sistemática y metaanálisis

Abstract Introduction: Massive bleeding in civilian trauma patients leads to dilutional coagulopathy. Transfusion with high plasma:red blood cell (RBC) ratio has been effective in reducing mortality in war trauma patients. However, in civilian trauma the evidence is controversial. Objective: To assess the impact on mortality of high vs low plasma:RBC ratio transfusion, in civilian trauma patients with massive bleeding. Methods: A systematic review and meta-analysis, including observational studies and clinical trials, was conducted. Data bases were systemically searched for relevant studies between January 2007 and June 2019. The main outcome was early (24-hours) and late (30-day) mortality. Fixed and random effects models were used. Results: Out of 1295 studies identified, 33 were selected: 2 clinical trials and 31 observational studies. The analysis of observational trials showed both decreased early mortality (odds ratio [OR] 0.67; 95% confidence interval [CI], 0.60-0.75) and late mortality (OR 0.79; 95% CI, 0.71-0.87) with the use of high plasma:RBC ratio transfusion, but there were no differences when clinical trials were evaluated (OR 0.89; 95% CI, 0.64-1.26). The exclusion of patients who died within the first 24 hours was a source of heterogeneity. The Injury Severity Score (ISS) altered the association between high plasma:RBC ratio and mortality, with a reduced protective effect when the ISS was high. Conclusion: The use of high vs low plasma: RBC ratio transfusion, in patients with massive bleeding due to civil trauma, has a protective effect on early and late mortality in observational studies. The exclusion of patients who died within the first 24 hours was a source of heterogeneity.

Resumen Introducción: El sangrado masivo en los pacientes con trauma civil propicia el desarrollo de coagulopatía dilucional. La transfusión de plasma y glóbulos rojos con una relación alta ha sido efectiva para disminuir la mortalidad en pacientes con trauma de guerra; sin embargo, su evidencia en trauma civil es controversial. Objetivo: Evaluar el efecto sobre la mortalidad de la transfusión de plasma: glóbulos rojos con relación alta (TPGR-RA) versus baja, en pacientes con sangrado masivo por trauma civil. Métodos: Se realizó una revisión sistemática y metaanálisis de estudios observacionales y experimentos clínicos publicados en el periodo de enero de 2007 a junio de 2019. El desenlace principal fue mortalidad temprana (24 horas) y tardía (30 días), utilizando el modelo de efectos fijos y aleatorios. Resultados: De 1.295 estudios identificados se incluyeron 33: dos experimentos clínicos y 31 estudios observacionales. El uso de TPGR-RA mostró una disminución de la mortalidad temprana (OR 0,67; IC 95 %, 0,60-0,75) y tardía (OR 0,79; IC 95 %, 0,71-0,87) cuando se analizaron los estudios observacionales, pero no hubo diferencias cuando se evaluaron los experimentos clínicos (OR 0,89; IC 95 %, 0,64-1,26). La exclusión de pacientes que fallecieron en las primeras 24 horas fue una fuente de heterogeneidad. La gravedad del trauma, ISS (por las iniciales en inglés de injury severity score)modificó la asociación entre la TPGR-RA y mortalidad, siendo menor el efecto protector cuando el ISS era alto. Conclusiones: El uso de TPGR-RA en pacientes con trauma civil y transfusión masiva (TM) tiene efecto protector sobre la mortalidad en los estudios observacionales. La exclusión de pacientes fallecidos en las primeras 24 horas fue causa de heterogeneidad.

Blood components requests at an orthopedic hospital: a critical survey

Abstract Introduction The correct completion of the blood components request form is the starting point to ensure good transfusion care. Many guidelines have been developed to search for hemoglobin values that trigger the need for transfusion and show the importance of Patient Blood Management, a scientific evidence-based approach in processes where transfusion is a possibility, such as in elective surgeries. Objective The cross-sectional study aimed to analyze the transfusion requests at a complex orthopedic hospital over a one-year period. Method The completion quality was classified as Good, Regular, Bad or Very Bad, according to the information given by the physician. Transfusion medicine professionals analyzed the transfusion indication reported on the request form and classified it as Correct, Not based on Patient Blood Management (PBM), in accordance or not with the institutional Maximum Surgical Blood Order Schedule, Impossible to evaluate due to lack of information on the form, and Incorrect. Results The study categorized the completion quality of 2011 requests as Good (8.80%), Regular (9.30%), Bad (72.75%) and Very Bad (9.15%). Analysis of the indications revealed that 54.90% of the requests were in accordance with the current blood transfusion recommendations, and on 23.12% of the forms this field had not been filled out. Conclusion The majority of blood components (63%) requests are in tune with current blood transfusion recommendations, despite the great number of incorrectly completed forms; nevertheless, it is mandatory to reach much better appropriateness rates.

What are the perspectives for blood donations and blood component transfusion worldwide? A systematic review of time series studies

ABSTRACT BACKGROUND: Analysis of the literature suggests that changes relating to blood donations and blood component transfusion are occurring due to the aging of the population. OBJECTIVE: To gain better understanding of the demand and supply of these inputs over time, and to identify the main associated demographic characteristics. DESIGN AND SETTING: Systematic review conducted on time series relating to blood donations and blood component transfusions worldwide. METHODS: A systematic review of the literature was conducted based on articles that presented time series relating to blood donation or blood component transfusion. RESULTS: We found 1,814 articles. After the deletion process, only thirteen were read. Overall, these suggested that there is increasing demand for blood components and decreasing donation. The existence of seasonality regarding blood donation was pointed out. Men usually donated more blood and demanded more blood components than women. Approximately 50% of blood transfusions were performed in people aged ≥ 60 years. CONCLUSIONS: This analysis on articles that presented time series relating to blood donations and blood component transfusion showed that aging of the population was the main factor associated with the increasing demand for blood and the decreasing supply of blood.

Effect of transfusion convalescent recovery plasma in patients with coronavirus disease 2019 / 中南大学学报(医学版)

OBJECTIVES@#To evaluate curative effects of coronavirus disease 2019 (COVID-19) patients by the transfusion of other convalescent plasma.@*METHODS@#Retrospective analysis of the clinical data of 18 patients with severe and critical COVID-19, who were hospitalized in the ICU of Xianghu Branch of the First Affiliated Hospital of Nanchang University from February 1 to March 15, 2020. Patients were subdivided into an experimental group (=6, who had transfused the plasma) and an observation group (=12, who had no plasma transfusion). Basic clinical data and prognosis indexes of these two groups were compared. Moreover, for the experimental group, the dynamic changes of blood oxygen saturation before and after the transfusion, the changes of lymphocyte absolute value 48 hours after the transfusion, and the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid were analyzed.@*RESULTS@#There were no significant differences in age, gender, blood type and other basic clinical data between the two groups (all >0.05).There were no significant differences in ventilator machine weaning time, extracorporeal membrane oxygenation (ECMO) weaning time, body temperature recovery to normal time, and hospitalization days between these two groups (all >0.05). For the experimental group, before, during and after the convalescent plasma transfusion, the blood oxygen saturation of all 6 patients at all time (1, 6, 8, 12, 24, 36, and 48 h) was more than 90%, and there was no significant fluctuation. There were 3 patients whose absolute value of lymphocyte was increased 48 hours after the transfusion, and the remaining was decreased. There were 5 patients whose SARS-CoV-2 nucleic acid detection turned negative 48 hours after the transfusion, accounting for 83.3%.@*CONCLUSIONS@#Transfusion of convalescent plasma will not affect outcomesof COVID-19 patients, which can neutralize SARS-CoV-2 in patients and reduce the loading capacity of SARS-CoV-2.

Clinical Application of Preoperative Autologous Blood Donation in Selective General Surgery / 中国实验血液学杂志

OBJECTIVE@#To study the clinical effects of preoperative autologous blood donation (PABD) in selective general surgery.@*METHODS@#Paired study was performed in PABD group with 70 PABD cases screened from selective general surgery during the period from November 2017 to August 2018 in our hospital, and the control group included 70 cases without preoperative autologous blood donation, the baseline data before surgery were not significantly different. The transfusion quantities of allogeneic RBC and plasma, the levels of perioperative hemoglobin and platelets, the time and expense of hospitalization were compared between two groups.@*RESULTS@#The levels of Hb and Plt in PABD group before and after blood collection were determined as follows: 138.26±14.73 g/L vs 127.52±13.36 g/L (P＜0.05) and (221.67±52.86)×10/L vs (198.35±52.65)×10/L (P＞0.05) respectively. The analysis of allo-RBC and allo-plasma transfusion in PABD group and control group showed that: the quantity of allogeneic RBC transfusion was 0.20±0.71 U and 0.89±0.97 U, and the quantity of allogeneic plasma transfusion was 30.43±100.81 ml and 106.52±152.61 ml (P＜0.05) respectirdy during perioperation. The comparison results of preoperative Hb and plt in PABD group and control group were 135.65±14.16 g/L vs 134.15±11.98 g/L and (270.36±58.28)×10/L vs (271.67±65.02) ×10/L respectively. The levels of postoperative Hb and plt in PABD group and control group were 120.24±14.40 g/L vs 121.20±14.30 g/L at 1 d after operation, and (241.80±63.58)×10/L vs (241.30±69.11)×10/L at 1 d after operation respectively; 123.15±13.80 g/L vs 121.65±14.33 g/L at 3 d after operation and (251.26±72.94)×10/L vs (255.54±73.85)×10/L at 3 d after operation; 122.78±13.92 g/L and 122.00±13.82 g/L (before discharge) and (262.50±80.96)×10/L and (264.56±71.08)×10/L (before discharge, platelet). These data were not statistically different (P＞0.05). The hospitalization time was 14.84±3.37 days and 14.84±2.24 days, respectively, without statistical difference (P＞0.05) in two groups. The expenses of hospitalization and the blood transfusion in two groups were 50627.27±9889.45 RMB and 50979.43±8195.00 RMB; 354.39±362.57 RMB and 684.02±425.53 RMB (P＜0.05).@*CONCLUSION@#The application of PABD reduces the use of allogeneic blood and costs for patients undergoing selective surgery with blood losts of 1000 ml.

Analysis of Related Factors of Adverse Transfusion Reactions / 中国实验血液学杂志

OBJECTIVE@#To investigate the related factors of adverse reactions of blood transfusion, and clinical precautions so as to reduce the adverse reactions.@*METHODS@#Data of 2108 patients with allogeneic transfusion in our hospital from January 2017 to June 2017 collected and analyzed.@*RESULTS@#These patients received 15 244 time of blood transfusion, and 213 time of adverse reactions occurred in 178 patients in totality, the incidence is 1.4%, and there was no significant difference between the male (1.31%) and female (1.53%). The main type of transfusion reaction were allergy (73.23%), FNHTR (11.74%) and TACO (10.80%). Among all kinds of blood components, the incidence of adverse reactions of apheresis platelet transfusion was the highest (4.31%), significantly higher than that of cryoprecipitate and other blood components. The incidence rate of adverse reactions of blood transfusion in the hematopathy patients was 2.56%, significantly higher than that of immune diseases (1.48%), cancer diseases (1.28%) and other diseases (1.08%), (P＜0.01). The rate of transfusion history of apheresis platelets was 42.67% (the incidence of adverse reactions was 4.31%), significantly higher than other groups (P＜0.01); the rate of transfusion history of cryoprecipitate was 4.11% (the incidence of adverse reaction was 0.45%), significantly lower than other groups (P＜0.05). Among the disease types, the rate of transfusion history in the hematopathy patients was 48.79% (the incidence of adverse reaction was 2.56%), significantly higher than that of other groups (P＜0.01). The incidence of drug allergy in patients with the adverse reactions to blood transfusion was 11.25%, significantly higher than that of patients without adverse reactions (4.71%) (P＜0.01).@*CONCLUSION@#The main risk factors of adverse reactions of blood transfusion are as follows: blood varieties, disease type, transfusion history and drug allergy history. For the patients with transfusion, multiple factors should be controlled, so as to reduce the adverse reactions.

Guía de cuidados de enfermería para la administración de la sangre y sus componentes (Revisión integrativa) / Nursing Care Guide for the administration of blood and its components (integrative review) / Guia de cuidados de enfermagem para a administração de sangue e seus componentes (revisão integrativa)

Resumen 13. El objetivo de esta investigación fue identificar la mejor evidencia científica que respalda el cuidado de enfermería a las personas que reciben una transfusión de sangre y sus componentes. La metodología siguió las pautas de la revisión integrativa partiendo de una pesquisa general a partir de la que se redactó una pregunta utilizando el formato PCC (Población, concepto y contexto); se estableció una estrategia de búsqueda de información en bases de datos en idioma español, inglés y portugués. Se llevó a cabo la selección y análisis crítico e interpretación de la evidencia encontrada. Se identificó inicialmente un total de 3543 artículos, de los que se removió 3513 (por duplicación) y se excluyó 30 (por título); por tanto, se seleccionó 16. Como resultado, se destaca los cuidados de enfermería antes, durante y posterior a la administración de los hemocomponentes, relacionados con el receptor, calidad del producto, materiales, prevención y valoración e intervención oportuna ante eventuales reacciones adversas. Se concluye que los cuidados de enfermería establecidos son semejantes entre los diferentes documentos, esta revisión integrativa se considera una guía óptima, para que los profesionales apliquen las diferentes actividades descritas para mejorar la calidad del procedimiento de transfusión de hemocomponentes en las instituciones de salud.

Abstract 17. The objective of this research was to identify the best scientific evidence that supports nursing care for people who receive a transfusion of blood and its components. The methodology followed the guidelines of the integrative review based on a general survey from which a question was written using the PCC format (Population, concept and context); an information search strategy was established in Spanish, English and Portuguese databases. The selection and critical analysis and interpretation of the evidence found was carried out. A total of 3543 articles were initially identified, of which 3513 were removed (by duplication) and 30 were excluded (by title); therefore, 16 were selected. As a result, the nursing care before, during and after the administration of blood components, related to the recipient, product quality, materials, prevention and assessment and timely intervention in the event of adverse reactions is highlighted. It is concluded that the established nursing care is similar among the different documents, this integrative review is considered an optimal guide for professionals to apply the different activities described to improve the quality of blood transfusion procedure in health institutions.

Resumo 21. O objetivo desta pesquisa foi identificar as melhores evidências científicas que sustentam o cuidado de enfermagem às pessoas que recebem transfusão de sangue e seus componentes. A metodologia seguiu as diretrizes da revisão integrativa com base em uma pesquisa geral da qual uma questão foi escrita usando o formato PCC (População, conceito e contexto); uma estratégia de busca de informações foi estabelecida em bancos de dados espanhóis, ingleses e portugueses. A seleção e análise crítica e interpretação das evidências encontradas foram realizadas. Um total de 3543 artigos foram inicialmente identificados, dos quais 3513 foram removidos (por duplicação) e 30 foram excluídos (por título); portanto, foram selecionados 16. Como resultado, destaca-se o cuidado de enfermagem antes, durante e após a administração dos componentes sanguíneos, relacionado ao receptor, qualidade do produto, materiais, prevenção e avaliação e intervenção oportuna em caso de reações adversas. Conclui-se que a assistência de enfermagem estabelecida é semelhante entre os diferentes documentos, sendo essa revisão integrativa considerada um guia ótimo para que os profissionais apliquem as diferentes atividades descritas para melhorar a qualidade do procedimento de transfusão sanguínea nas instituições de saúde.

Hemocomponentes en urgencias: tratamiento vital para los pacientes politraumatizados / Blood products in the emergency room: vital treatment for polytraumatized patients

Introducción: La principal causa de mortalidad temprana en pacientes politraumatizados es la hipovolemia secundaria a hemorragia masiva. La terapia con hemocomponentes y cristaloides constituye un mecanismo esencial y salvavidas en estas situaciones como medida de reemplazo de volumen. De la misma manera los pacientes con lesiones traumáticas graves tienen una disminución aguda significativa en el recuento de plaquetas circulantes que los hace candidatos a la transfusión de componentes plaquetarios; sin embargo, el uso de estos componentes sanguíneos puede traer consigo desenlaces no deseados como aumento en la mortalidad. Si bien muchos estudios revelan un aumento de la mortalidad como desenlace asociado al uso de hemocomponentes, otros establecen su uso como una medida reductora de este desenlace. Objetivo: Exponer las principales indicaciones de hemocomponentes en los pacientes politraumatizados, así como relacionar los eventos adversos asociados a su uso que influyen sobre la mortalidad y el tiempo de hospitalización de estos pacientes. Desarrollo: La mortalidad asociada al uso de hemocomponentes aún es un tema controvertido. En la hemorragia masiva el apoyo transfusional rápido y eficiente es esencial en el tratamiento y la atención de politraumatismos, de ahí que sea necesario contar con protocolos de transfusión que mejoren los resultados y disminuyan las complicaciones. Además, se identificó la necesidad de nuevos estudios sobre el tema para mejorar estos protocolos y reducir las complicaciones.(AU)

Introduction: The main cause of early mortality in polytrauma patients is hypovolemia secondary to massive hemorrhage. Hemocomponent and crystalloid therapy is an essential and life-saving mechanism in these situations as a measure of volume replacement. In the same way, patients with severe traumatic injuries have a significant acute decrease in circulating platelet counts that makes them candidates for transfusion of platelet components; However, the use of these blood components can lead to unwanted outcomes such as increased mortality. Although many studies reveal an increase in mortality as an outcome associated with the use of blood components, others establish its use as a reducing measure of this outcome. Objective: to present the main indications of blood components in polytrauma patients, as well as to relate the adverse events associated with their use that influence the mortality and hospitalization time of these patients. Devlopment: Mortality associated with the use of blood components is still a controversial issue. In massive hemorrhage, rapid and efficient transfusion support is essential in the treatment and care of polytrauma, hence it is necessary to have transfusion protocols that improve results and reduce complications. In addition, the need for new studies on the subject to improve these protocols and reduce complications was identified(AU)

Medicina y Cirugía sin Sangre La Experiencia de Solca Guayaquil / Medicine and Surgery without Blood The Experience of Solca Guayaquil

Introducción: Los riesgos asociados con las Transfusiones de Sangre Alogénicas (TSA) son ampliamente conocidos y han contribuido a nuevos paradigmas de tratamiento para la medicina y cirugía sin sangre. Por tanto, es importante contar con estrategias terapéuticas efectivas y prácticas que sirvan como alternativas al uso de TSA. Este informe describirá las estrategias aplicadas a los pacientes de este reporte. Métodos: Estudio retrospectivo descriptivo de alternativas a la TSA utilizadas en SOLCA Guayaquil con pacientes que no aceptaron TSA bajo ninguna circunstancia, entre los años 2011 y 2017. La estrategia terapéutica se basó en un diagnóstico temprano y un tratamiento agresivo de la anemia y cualquier tipo de sangrado activo. Se utilizó eritropoyetina, hierro y folato, según requerimientos del paciente. Todos los pacientes quirúrgicos recibieron ácido tranexámico y otros hemostáticos tópicos según necesidad. Resultados: De 73 pacientes oncológicos, el 68.5 % eran no quirúrgicos, de este grupo el 62 % recibió quimioterapia. La hemoglobina aumentó hasta 12.6 g/dL. Por tratamiento global por paciente se administraron hasta 3000 mg de hierro, 140.000 unds de eritropoyetina y megadosis de vitamina C fue aplicada con una media de 24 gramos. Todos los pacientes aumentaron sus niveles de hemoglobina en un promedio de 25 días. Conclusión: Es esencial iniciar un tratamiento temprano, preventivo y coordinado con un equipo multidisciplinario comprometido a estos esquemas. Los pacientes respondieron bien a los medicamentos y las dosis recibidas y no se informaron efectos secundarios. También podemos ver que estas estrategias son efectivas y factibles de aplicar.

Introduction: Risks associated with the Allogeneic Blood Transfusions (ABT) are widely known and have contributed to new treatment paradigms for bloodless medicine and surgery. Therefore, it is essential to have effective therapeutic strategies that serve as alternatives to ABTs. This report describes the strategies applied to patients in this paper. Methods: A Retrospective descriptive study of ABT alternatives used in SOLCA Guayaquil with patients who did not accept ABTs under any circumstances, between 2011 and 2017. The therapeutic strategy was an early diagnosis and an aggressive treatment of anemia and any active bleeding. Erythropoietin, iron, and folate were applied, according to the patient's requirements. All surgical patients received tranexamic acid and other hemostatics as needed. Results: Of 73 cancer patients, 68.5% were non-surgical, 62% of the group received chemotherapy. For global treatment per patient, up to 3000 mg of iron was administered, 140,000 units of erythropoietin and megadoses of vitamin C were applied with an average of 24 grams. All patients increased their hemoglobin levels by an average of 25 days. All patients increased their hemoglobin levels by an average of 25 days. Conclusion: It is essential to start early treatment, prevent and coordinate with a multidisciplinary team committed to these schemes. The patients responded well to the medications, and the doses received, and no side effects were reported. We can also see that these strategies are practical and feasible to apply.

Adequação das atividades da intervenção "administração de hemoderivados" da classificação das intervenções de enfermagem para pacientes adultos / Adequacy of the activities in "blood products administration", of the nursing interventions classification, for adult patients / Adecuación de las actividades de la intervención "administración de hemoderivados" de la clasificación de intervenciones de enfermería para pacientes adultos

Introdução: a prevenção e/ou identificação precoce de reações transfusionais dependem de vigilância e cuidados diretos realizados pelos enfermeiros de forma segura e baseada em evidências. A Administração de Hemoderivados, uma intervenção na Classificação de Intervenções de Enfermagem, compreende 27 atividades que não foram validadas anteriormente. Objetivo: avaliar a adequação das atividades da intervenção da Classificação das Intervenções de Enfermagem Administração de Hemoderivados para pacientes adultos. Métodos: a adequação das atividades da Administração de Hemoderivados para pacientes adultos foi avaliada por 73 enfermeiros intensivistas de um hospital particular no Brasil. Atividades com médias ponderadas <0,80 e >0,50 foram classificadas como secundárias. Atividades com médias ponderadas ≥0,80 foram classificadas como principais. Atividades com razões ponderadas <0,50 foram consideradas não essenciais. Além disso, as atividades, dentro de suas classificações como principais ou secundárias, foram tipificadas pelos pesquisadores em seis subgrupos: cuidado basal; cuidado durante transfusão; cuidado após transfusão; cuidados durante e após transfusão; cuidados basal, durante e após transfusão; e cuidado após reação. Resultados: 22 atividades foram classificadas como principais, quatro foram classificadas como secundárias (dois cuidados basais, um cuidado durante e um cuidado após transfusão) e uma foi considerada não essencial (obter amostra do sangue e amostra da primeira urina após a reação à transfusão). Conclusões: na opinião dos enfermeiros intensivistas, a adequação da maioria das atividades da intervenção NIC Administração de Hemoderivados foi apoiada. Algumas mudanças na redação de algumas atividades podem melhorar a clareza e a precisão. Nossos resultados podem contribuir para futuros estudos de validação de conteúdo com maiores amostras de enfermeiros de diferentes especialidades que realizam transfusões rotineiramente, como enfermeiros oncologistas.(AU)

Introduction: prevention and/or early identification of transfusion-associated reactions rely on safe, evidence-based vigilance and direct care by nurses. Blood Products Administration, an intervention in the Nursing Interventions classification (NIC), comprises 27 activities that have not been previously validated. Objective: to evaluate the adequacy of the activities in the NIC intervention Blood Products Administration for adult patients. Methods: the adequacy of Blood Products Administration activities for adult patients was evaluated by 73 critical care nurses of a private hospital. Activities with weighted ratios (WR) <0.80 but >0.50 were labeled as minor. Activities with WR ≥0.80 were classified as major. Activities with WR <0.50 were discarded. Additionally, the activities within their classifications as major or minor were typified by the researchers in six subgroups: Baseline care; Care throughout transfusion; Care...(AU)

Introducción: la prevención y / o identificación temprana de las reacciones a la transfusión dependen de la vigilancia y de la atención segura de enfermería, en base a evidecias. La administración de hemoderivados, una intervención en la Clasificación de intervenciones de enfermería, comprende 27 actividades que no han sido validadas antes. Objetivo: evaluar la idoneidad de las actividades de intervención de la Clasificación de Intervenciones de Enfermería Administración de Hemoderivados para pacientes adultos. Métodos: 73 enfermeras de cuidados intensivos de un hospital privado de Brasil evaluaron la idoneidad de las actividades de administración de hemoderivados para pacientes adultos. Las actividades con promedios ponderados <0,80 y> 0,50 se clasificaron como secundarias. Las actividades con promedios ponderados ≥0,80 se clasificaron como principales. Las actividades con relaciones ponderadas <0,50 se consideraron no esenciales. Además, las actividades dentro de sus clasificaciones como principales o secundarias fueron tipificadas por los investigadores en seis subgrupos: atención basal; precaución durante la transfusión; cuidado después de la transfusión; cuidado durante y después de la transfusión; cuidado basal durante y después de la transfusión; y cuidado después de la reacción. Resultados: 22 actividades se clasificaron como principales, cuatro se clasificaron como secundarias (dos cuidados iniciales, uno durante y uno después de la transfusión) y uno se consideró no esencial (obtención de muestra de sangre y muestra de la primera orina después de la reacción a la transfusión). Conclusiones: los enfermeros de cuidados intensivos apoyan la idoneidad de la mayoría de las actividades de intervención NIC Administración de hemoderivados. Ciertas alteraciones en la redacción de algunas actividades podrían mejorar la claridad y la precisión. Nuestros hallazgos podrían contribuir a futuros estudios de validación de contenido con muestras más amplias de enfermeros de diferentes especialidades que realizan transfusiones de forma rutinaria, tales como los enfermeros oncológicos. (AU)

Plan nacional para la promoción de la donación voluntaria de sangre en el Perú, 2018-2021: Documento técnico / National plan for the promotion of voluntary blood donation in Peru, 2018-2021: Technical document

El documento contiene: la finalidad, base legal, ámbito de aplicación, disposiciones generales y específicas, recursos, presupuestos, financiamiento, monitoreo y evaluación y responsabilidades del plan nacional para la promoción de la donación voluntaria de sangre en el Perú.